US 2022/0175937 A1Published application

Selected artemisinin dimers for the treatment of lashmaniasis

OwnerMahmoud A. ElSohly, Waseem Gulinventors

Life of this patent

Estimating the term…

Abstract

New compositions are provided containing artemisinin dimers with high activity as anti-protozoal agents, including anti-malarial and anti-leishmanial properties, and methods for the treatment of protozoal infections, including malaria or leishmaniasis.

Claims9

Dependent claims

Artemisinin dimers having the formula:

Dependencies are inferred from the claim text.

Facts

Application: 17/433,594Filed 25 Feb 2020
Priority: 26 Feb 2019
Published: 9 Jun 2022
Term ends: Not estimatedThe source records don’t support an estimate.

Classification16 codes

A61K 31/255
Esters, e.g. nitroglycerine, selenocyanates: of sulfoxy acids or sulfur analogues thereof
A61K 47/55
The modifying agent being an organic compound: the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire…
A61K 31/357
Having oxygen as the only ring hetero atom, e.g. fungichromin: having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
A61K 31/4433
Containing further heterocyclic ring systems: containing a six-membered ring with oxygen as a ring hetero atom

Family

Application62/810,922Us provisional application · filed 26 Feb 2019
US 12,156,915 B2Related patent
US 2022/0175937 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results